M S Panbio Pharm Llc Pharmaceutical Import Profile — Russia (DGFT 2022–2026)

Name: M S Panbio Pharm Llc Pharmaceutical Import Records from India — 2 Products, $200.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M S Panbio Pharm Llc — Pharmaceutical Importer Profile (2026) | 2 Products, $200.0K Trade | TransData Nexus

M S Panbio Pharm Llc

Pharmaceutical Importer · Russia · Nutritional Supplements Focus · $200.0K Total Trade · DGFT Verified

M S Panbio Pharm Llc is a pharmaceutical importer based in Russia with a total trade value of $200.0K across 2 products in 1 therapeutic categories. Based on 4 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M S Panbio Pharm Llc sources from 1 verified Indian supplier, with Panacea Biotec Pharma Limited accounting for 100.0% of imports.

M S Panbio Pharm Llc — Import Portfolio & Supplier Network

M S Panbio Pharm Llc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M S Panbio Pharm Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Panacea Biotec Pharma Limited	$290.3K	7	100.0%

M S Panbio Pharm Llc sources from 1 verified Indian supplier across 5 distinct formulations. The sourcing is highly concentrated — Panacea Biotec Pharma Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does M S Panbio Pharm Llc Import?

Formulation	Value	Ships
Nimulid nimesulide orodispersible tablets Each uncoated ordispersible tablets contains nimesulide BP....100 MG	$100.0K	2
Kondro nova capsules glucosamine sulphate 250MG + chondroitin sulphate 200MG Each hard gelatin capsule contains	$100.0K	2
Alphadol capsules Each soft gelatin capsule contains alfacalcidol 0.25 MCG & calcium carbonate 500 MG equivalent to	$40.6K	1
Nimulid 1% gel 60 gms for external use nimesulide 1% gel for external use b/n.60523010 to 60523013 m/d.09/2023	$29.9K	1
Alphadol ca capsules Each soft gelatincapsule contains alfacalcidol 0 25mcg calcium carbonate 500MG equivalent	$19.8K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Chondroitin	Nutritional Supplements	$100.0K	2	2.0%	6
2	Glucosamine	Nutritional Supplements	$100.0K	2	0.8%	12

M S Panbio Pharm Llc imports 2 pharmaceutical products across 1 categories into Russia totaling $200.0K.

M S Panbio Pharm Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M S Panbio Pharm LLC is a Russian pharmaceutical importer and distributor specializing in the procurement and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Headquartered in Reutov, Moscow Region, Russia, the company plays a significant role in the Russian pharmaceutical supply chain by sourcing a diverse range of pharmaceutical products from international markets, particularly India. This strategic sourcing enables M S Panbio Pharm LLC to offer a comprehensive portfolio of medications to meet the needs of the Russian healthcare sector.

The company's operations are characterized by a focus on importing finished pharmaceutical products rather than raw active pharmaceutical ingredients (APIs) or bulk drugs. This approach allows M S Panbio Pharm LLC to provide ready-to-use medications that comply with Russian regulatory standards, thereby facilitating efficient distribution within the country. By leveraging its international supplier network, the company ensures a steady supply of high-quality pharmaceutical products to the Russian market.

2Distribution Network

M S Panbio Pharm LLC's distribution network is centered in Reutov, Moscow Region, Russia, where its headquarters are located. The company operates multiple offices across the country, enhancing its logistical capabilities and ensuring efficient distribution of pharmaceutical products nationwide. While specific details about warehouse locations and logistics infrastructure are not publicly disclosed, the company's extensive network suggests a well-established system for managing the import and distribution of pharmaceutical goods.

The company's strategic positioning in Moscow Region facilitates access to major transportation routes, enabling timely delivery of products to various regions within Russia. This logistical advantage is crucial for maintaining a consistent supply chain and meeting the demands of the Russian healthcare market.

3Industry Role

M S Panbio Pharm LLC operates as a pharmaceutical importer and distributor within Russia's pharmaceutical supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company serves as a key intermediary between foreign manufacturers and the Russian market. This role involves ensuring that imported products meet Russian regulatory standards and are effectively distributed to meet the needs of healthcare providers and patients across the country.

The company's focus on importing finished pharmaceutical products, rather than raw APIs or bulk drugs, positions it as a critical player in the distribution segment of the pharmaceutical supply chain. This strategy allows M S Panbio Pharm LLC to offer a diverse range of ready-to-use medications, thereby contributing to the availability and accessibility of essential pharmaceutical products in Russia.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M S Panbio Pharm Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

M S Panbio Pharm LLC demonstrates a high degree of sourcing concentration, with a total import value of $200,000 USD from India across four shipments. The company's portfolio is entirely focused on two products—Chondroitin and Glucosamine—both imported from a single supplier, Panacea Biotec Pharma Limited. This single-source dependency indicates a strategic choice to maintain a streamlined supply chain and potentially leverage favorable terms with a trusted supplier.

However, this sourcing strategy also presents risks associated with over-reliance on a single supplier. Any disruptions in Panacea Biotec Pharma Limited's production or export capabilities could directly impact M S Panbio Pharm LLC's ability to meet market demand. The company's shipment data, consisting of seven shipments from this sole supplier, suggests a stable and ongoing relationship, which may mitigate some of these risks. Nonetheless, the lack of diversification in sourcing could pose challenges in the event of unforeseen supply chain disruptions.

2Supply Chain Resilience

M S Panbio Pharm LLC's supply chain resilience is closely tied to its exclusive partnership with Panacea Biotec Pharma Limited for the importation of Chondroitin and Glucosamine. While this focused sourcing strategy allows for streamlined operations, it also means that the company's supply chain is vulnerable to any disruptions affecting this single supplier. The absence of backup suppliers or alternative formulations indicates a potential area of concern for the company's supply chain resilience.

Importing Pharmaceuticals into Russia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Russia

1Regulatory Authority & Framework

In Russia, the regulation of pharmaceutical imports is governed by the Ministry of Health, which oversees the State Drug Registration Center (SDRC). The primary legislation guiding pharmaceutical imports is the Federal Law on the Circulation of Medicines (No. 61-FZ), which outlines the procedures for the registration and importation of medicinal products. This law ensures that all imported medicines meet the necessary quality, safety, and efficacy standards before entering the Russian market.

The SDRC is responsible for reviewing and approving the registration dossiers submitted by pharmaceutical companies, including those from foreign manufacturers. The registration process involves a comprehensive evaluation of the product's quality, safety, and efficacy data, as well as compliance with Russian regulatory requirements. This rigorous process aims to protect public health by ensuring that only safe and effective medicines are available to Russian consumers.

2Import Licensing & GMP

Import licensing in Russia requires that all pharmaceutical products, including those imported from India, obtain an import license and are subject to federal state control over the distribution of pharmaceuticals. This control is enforced by territorial authorities under the Health Supervisory Service of the Russian Federation (Roszdravnadzor) and constituent bodies of the Russian Federation. The purpose of this state supervision is to prevent, detect, and contain violations of the requirements of Russian legislation in the field of drug distribution.

M S Panbio Pharm Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

M S Panbio Pharm LLC's product strategy focuses on importing finished pharmaceutical formulations, specifically Chondroitin and Glucosamine, from India. These products are primarily used in the treatment of joint diseases and are categorized under nutritional supplements. The company's emphasis on these specific therapeutic areas suggests a strategic alignment with market demand for joint health supplements in Russia.

The decision to import these products may be driven by factors such as the prevalence of joint-related health issues among the Russian population and the availability of high-quality, cost-effective formulations from Indian manufacturers. By focusing on these therapeutic areas, M S Panbio Pharm LLC aims to address a significant segment of the Russian healthcare market, thereby enhancing its competitive position.

2Sourcing Profile

M S Panbio Pharm LLC's sourcing strategy is characterized by a focus on finished pharmaceutical formulations, particularly Chondroitin and Glucosamine, imported from a single supplier, Panacea Biotec Pharma Limited in India. This approach allows the company to maintain a streamlined supply chain and ensure consistent product quality. The choice to source from India may be influenced by the country's established reputation for producing high-quality pharmaceutical products at competitive prices.

The company's reliance on a

Frequently Asked Questions — M S Panbio Pharm Llc

What products does M S Panbio Pharm Llc import from India?

M S Panbio Pharm Llc imports 2 pharmaceutical products across 1 categories. Top imports: Chondroitin ($100.0K), Glucosamine ($100.0K).

Who supplies pharmaceuticals to M S Panbio Pharm Llc from India?

M S Panbio Pharm Llc sources from 1 verified Indian suppliers. The primary supplier is Panacea Biotec Pharma Limited (100.0% of imports, $290.3K).

What is M S Panbio Pharm Llc's total pharmaceutical import value?

M S Panbio Pharm Llc's total pharmaceutical import value from India is $200.0K, based on 4 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M S Panbio Pharm Llc focus on?

M S Panbio Pharm Llc imports across 1 categories. The largest: Nutritional Supplements (100.0%).

Get Full M S Panbio Pharm Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.